Back | Next |
home / stock / insm / insm message board
Subject | By | Source | When |
---|---|---|---|
Anyone here from the old days? 2008 ish? | Reluctant Observer | investorshub | 09/13/2017 1:00:20 AM |
Wow that`s a lot of cash. More than | blueyedcatch | investorshub | 09/12/2017 2:57:21 AM |
Insmed Announces Closing of Public Offering - https://finance.yahoo.com/news/ins | fireopal | investorshub | 09/11/2017 8:38:19 PM |
$INSM looks higher | tfusari | investorshub | 09/11/2017 7:37:02 PM |
not yet | John Kent | investorshub | 09/08/2017 2:56:43 PM |
Thanks man. Did you take a | Crazyjake27 | investorshub | 09/08/2017 2:27:18 PM |
I am happy for you great work | John Kent | investorshub | 09/08/2017 2:25:30 PM |
I'm out at. 30.25. From 24. | Crazyjake27 | investorshub | 09/08/2017 2:07:58 PM |
I`m wondering how fast, with the new FDA | blueyedcatch | investorshub | 09/08/2017 12:53:39 AM |
good luck hope it works for you | John Kent | investorshub | 09/07/2017 4:49:47 PM |
Trailing stop man. Trying to make some | Crazyjake27 | investorshub | 09/07/2017 4:48:41 PM |
this was pumped up to sell shares good | John Kent | investorshub | 09/07/2017 4:47:16 PM |
After the offering they will have around 450 | Crazyjake27 | investorshub | 09/07/2017 4:46:00 PM |
There is no revenue yet but and approved | Crazyjake27 | investorshub | 09/07/2017 4:43:15 PM |
Nonsense pure nonsense. Its not an FDA approval | John Kent | investorshub | 09/07/2017 4:31:59 PM |
Only around 12 millions shares. This is | Crazyjake27 | investorshub | 09/07/2017 3:29:01 PM |
Plenty of working capital! $INSM is a great | crudeoil24 | investorshub | 09/07/2017 2:34:18 PM |
I TRIED GETTING FILLED | TheFinalCD | investorshub | 09/07/2017 2:33:32 PM |
Heard we got news today | BoilerRoom | investorshub | 09/07/2017 1:13:24 PM |
That`s a lot of cash for? IPLEX? | blueyedcatch | investorshub | 09/07/2017 12:35:18 PM |
News, Short Squeeze, Breakout and More Instantly...
AlloVir Inc. (ALVR) is expected to report $-0.16 for Q1 2024 Inter & Co. Inc. (INTR) is expected to report $0.08 for Q1 2024 Array Technologies Inc. (ARRY) is expected to report $-0.06 for Q1 2024 Sphere 3D Corp. (ANY) is expected to report $-0.23 for Q1 2024 Alpine Immune Sci...
Insmed Reports First-Quarter 2024 Financial Results and Provides Business Update PR Newswire — ARIKAYCE ® (amikacin liposome inhalation suspension) Total Revenue of $75.5 Million for the First Quarter of 2024, Reflecting 16% Annual Growth Over the First Qua...
Insmed To Present at the BofA Securities Health Care Conference 2024 PR Newswire BRIDGEWATER, N.J. , May 7, 2024 /PRNewswire/ -- Insmed Incorporated (Nasdaq:INSM), a global biopharmaceutical company on a mission to transform the lives of patients with seriou...